Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Pyrovalerone
Introduction
Overview
Overview
Pyrovalerone (Centroton, Thymergix) is a stimulant drug developed in the late 1960s and used in France and some other European countries. This drug is now rarely prescribed due to problems with abuse and dependence [1] , but is still rarely prescribed either as an appetite suppresant or for treating chronic fatigue and lethargy. [2] Side effects of pyrovalerone include loss of appetite, anxiety, insomnia and tremor. Withdrawal syndrome following abuse causes depression. [3] Pyrovalerone is a Schedule V drug in the USA. It is closely related to some other stimulant drugs such as prolintane and MDPV
CAS# 1147-62-2 (pyrovalerone hydrochloride); 3563-49-3 (pyrovalerone freebase)
References
References
- ↑ Deniker P, Loo H, Cuche H, Roux JM. Abuse of pyrovalerone by drug addicts. Annales Medico-Psychologiques (Paris) 1975 Nov;2(4):745-8.
- ↑ Gardos G, Cole JO. Evaluation of pyrovalerone in chronically fatigued volunteers. Current Therapeutic Research, Clinical and Experimental. 1971 Oct;13(10):631-5.
- ↑ http://www.biam2.org/www/Etr8623.html